Ström & Gulliksson highly recommended and individual attorneys mentioned by Intellectual Asset Management (IAM)
The Intellectual Asset Management (IAM) Patent 1000 listing focuses exclusively on patent practice and has firmly established itself as the definitive ‘go-to’ resource for those seeking world-class legal patent expertise. This year we retain our position as highly recommended in the IAM Patent 1000 and some of our patent attorneys have received well deserved special mentions. Further, Ström & Gulliksson is also included among the patent law firms recommended befor the European Patent Office (EPO).
We are grateful to, once again, get the recognition of being highly recommended for patent work in Sweden and before the European Patent Office by IAM Patent 1000.
– Recognitions like this are just as much a reward for our hard and dedicated work, as a welcoming encouragement and incentive to keep developing to protect our position as a top choice for innovative companies. Our focus is to provide our clients with a comprehensive range of quality services and employees with strong professional expertise and high-level skills, says Christian Arkelius, partner and head of Ström & Gullikssons office in Stockholm.
Roos, Andersson, Berglund and Arkelius – selected as recommended individuals
Recommended Individuals – prosecution:
“The service at Ström & Gulliksson is delivered to the highest possible standard, and its super personable attorneys are reliable, helpful and always look to find the most budget-friendly solutions for their clients.” The ensemble’s approach to asset protection, coupled with its artful management of immense portfolios, has earned it the trust of high-flyers such as Rolls-Royce, IKEA and Spotify. In Malmö, Rikard Roos, Björn Andersson and Magnus Berglund set the tone. “Rikard is one of the best patent attorneys in town and he always brings great value to any matter he takes on. As an excellent communicator, he is extremely skilled in inter partes cases and oral proceedings, where he uses his legal and scientific knowledge to stay one step ahead of the game and win the case. Rikard is definitely someone you want on your side, and not as an opposing party!” “The go-to for tricky software briefs, Björn’s devotion and commitment, as well as his attention to detail are most impressive, while his willingness to understand a company’s wider business objectives is greatly valued.” In the pharmaceutical and life sciences sectors, Berglund has a deep appreciation for the subject matter and a down-to-earth approach that sits well with the inventors he collaborates with. Over in Stockholm, “Christian Arkelius is extensively experienced and highly skilled at handling complex contentious patent cases. He is extremely hard working, detail oriented and really reliable in tough situations. He can be entrusted with the toughest cases in Europe.”
More about IAM
IAM is the trusted source of worldwide news, analysis and data on the management of intellectual property as a key business asset. It keeps in-house counsel up to speed with the global issues and strategies that matter, giving you the detail and depth you need to operate successfully.
IAM gives you critical insight into the market landscape with a wide range of regular special and panel reports and surveys, helping you monitor your performance against its peers. Navigate the world’s IP landscape with our collaborative community research, and in-depth reviews across key industry sectors. Develop your understanding of key market developments with our weekly long-read analysis.
More about European Patent Office
In 2021 the European Patent Office (EPO) received a record 188,600 applications and Pharmaceutical and biotechnology applications increased, and the volume of applications in areas such as digital communications and medical technology saw nearly double-digit growth.
The pandemic is not thought to have significantly impacted innovation, though it does appear to have negatively affected some EPO functions; for example, oppositions are taking longer to process, with the 15-month target proving difficult to meet.
For more up to date information and statistics from the European Patent Office – visit this website!